Special Interview with Prof. Anthony Atala
On May 21, 2026, the Editorial Office of Plastic and Aesthetic Research (PAR) had the honor of interviewing Prof. Anthony Atala - one of the most influential pioneers in regenerative medicine, tissue engineering, and bioprinting.
The recording of this interview can be found below:
Interview Questions:
Q1: Over the past decade, your work has continuously pushed the boundaries from engineered tissues toward functional organ replacement. In your view, what are the most critical - and perhaps underestimated - barriers that still prevent bioprinting technologies from becoming routine clinical therapies, and how close are we to overcoming them?
Q2: In your recent work on "Precision exosome engineering for enhanced wound healing and scar revision," you highlight engineered exosomes as an emerging cell-free strategy for modulating tissue repair and fibrosis. From your perspective, how might this line of research influence the evolving role of regenerative medicine in plastic and aesthetic surgery - particularly in advancing more precise, biology-driven approaches to tissue repair and scar management - and what implications do you see for its future development within the broader field of Plastic and Aesthetic Research?
Q3: As regenerative medicine moves closer to clinical translation, how should the field balance rapid innovation, long-term safety, and ethical responsibility - especially as we move toward increasingly personalized and on-demand tissue and organ fabrication?
Q4: Looking ahead, do you envision regenerative medicine evolving beyond "tissue replacement" toward a more dynamic paradigm of biological system reprogramming? How might this shift redefine the long-term goals of tissue engineering and regenerative medicine?
Q5: As a pioneer in regenerative medicine who has successfully translated research from the laboratory to clinical application, what advice would you offer to early-career researchers aiming to make meaningful and lasting contributions in this rapidly evolving field?
About Prof. Anthony Atala:
Anthony Atala, MD, is internationally recognized as one of the most influential pioneers in regenerative medicine, tissue engineering, and bioprinting. As the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine (WFIRM), the W.H. Boyce Professor and Chair of Urology at Wake Forest School of Medicine, Dr. Atala has spent decades transforming visionary scientific concepts into clinical realities that are reshaping the future of medicine.
Widely regarded as a founding architect of modern regenerative medicine, Dr. Atala led the groundbreaking development of the world's first laboratory-engineered organ successfully implanted into a human patient, a milestone that revolutionized the field and opened entirely new possibilities for organ replacement therapies. He is also the creator of one of the first integrated 3D bioprinting systems for tissues and organs and remains a global leader in advancing bioprinting technologies for clinical applications.
Under his leadership, WFIRM has grown into one of the world's largest and most respected regenerative medicine research centers, bringing together more than 400 scientists, physicians, and engineers dedicated to developing cell therapies, engineered tissues, and regenerative solutions for over 40 different organs and tissues throughout the human body. To date, fifteen technologies developed in his laboratory have successfully reached clinical application, a remarkable achievement that underscores his extraordinary ability to bridge fundamental discovery and patient care.
Dr. Atala's scientific influence is unparalleled. He has authored more than 800 peer-reviewed publications, edited 25 influential academic books and 3 scientific journals, and holds over 250 national and international patents. His seminal contributions have helped define the scientific foundations of regenerative medicine while accelerating the translation of innovative therapies from bench to bedside.
His accomplishments have earned worldwide recognition. Dr. Atala is an elected member of the National Academy of Medicine, a Charter Fellow of the National Academy of Inventors, and a Fellow of the American Institute for Medical and Biological Engineering. His numerous honors include the Christopher Columbus Foundation Award, the World Technology Award in Health and Medicine, the Samuel D. Gross Prize, the Barringer Medal, the Gold Cystoscope Award, the Smithsonian Ingenuity Award, the Edison Award for Innovation, the R&D Innovator of the Year Award, and the TERMIS Lifetime Achievement Award.
Recognized by Scientific American as one of the world's most influential figures in biotechnology, by U.S. News & World Report as one of the "Pioneers of Medical Progress in the 21st Century," and by Nature Biotechnology as one of the world's leading translational researchers, Dr. Atala has repeatedly been at the forefront of scientific breakthroughs that redefine the future of healthcare. His work has been featured multiple times among Time magazine's Top Medical Breakthroughs of the Year and has fundamentally changed global perspectives on tissue regeneration, organ engineering, and personalized medicine.
More than a scientist, surgeon, inventor, and educator, Dr. Atala is a visionary whose pioneering contributions continue to inspire generations of researchers worldwide. Through his pioneering contributions to regenerative medicine, tissue engineering, and bioprinting, Dr. Atala has profoundly influenced both scientific discovery and clinical practice, helping shape the future of modern healthcare.
To learn more about Prof. Anthony Atala, please visit: https://school.wakehealth.edu/faculty/a/anthony-atala
Editor: Thea Meng
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Plastic and Aesthetic Research
